Eli Lilly to seek approval of obesity drug that could disrupt weight loss market – Financial Times

Business News

  1. Eli Lilly to seek approval of obesity drug that could disrupt weight loss market  Financial Times
  2. Powerful new obesity drug poised to upend weight loss care  Yahoo News
  3. Diabetes drug Mounjaro could be FDA approved for weight loss by late 2023: Eli Lilly  ABC News
  4. Eli Lilly says obesity drug tirzepatide resulted in weight loss of up to 34 pounds  CNBC
  5. Diabetic medication awaiting FDA approval for weight-loss  WHIO

Source: Business News

/by